Search research articles
Contact Us
Filters
Showing results (181-190 of 388) with videos related to
Page
of 39
Sort By:
Critical Reviews in Oncology/Hematology
|
June 9, 2019
Management of targeted therapies in cancer patients with chronic kidney disease, or on haemodialysis: An Associazione Italiana di Oncologia Medica (AIOM)/Societa' Italiana di Nefrologia (SIN) multidisciplinary consensus position paper
Nicola Silvestris, Antonella Argentiero, Laura Cosmai, et al.
The Oncologist
|
February 6, 2025
Updated overall survival in patients with prior checkpoint inhibitor therapy in the phase III TIVO-3 study
Miguel Zugman, David F McDermott, Bernard J Escudier, et al.
American Journal of Clinical Oncology
|
April 2, 2004
Docetaxel, carboplatin and concomitant radiotherapy for unresectable squamous cell carcinoma of the head and neck: pharmacokinetic and clinical data of a phase I-II study
Mario Airoldi, Luigi Cattel, Giorgio Cortesina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2007
Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma
Andrea Sartore-Bianchi, Fabio Gasparri, Arturo Galvani, et al.
Journal of Cellular Biochemistry
|
February 27, 2016
Endoplasmic Reticulum Ca(2+) Handling and Apoptotic Resistance in Tumor-Derived Endothelial Colony Forming Cells
Valentina Poletto, Silvia Dragoni, Dmitry Lim, et al.
Journal of Nephrology
|
July 24, 2015
Renal cancer in kidney transplanted patients
Giovanni M Frascà, Silvio Sandrini, Laura Cosmai, et al.
International Journal of Molecular Sciences
|
August 6, 2020
Non-Melanoma Skin Cancers: Biological and Clinical Features
Mauro Cives, Francesco Mannavola, Lucia Lospalluti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2007
Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin
Robert G Gish, Camillo Porta, Lucian Lazar, et al.
BMC Nephrology
|
May 12, 2026
Multimodal predictions of end stage chronic kidney disease from asymptomatic individuals for discovery of genomic biomarkers
Simona Rabinovici-Cohen, Daniel E Platt, Toshiya Iwamori, et al.
The Oncologist
|
December 28, 2022
Tivozanib in Patients with Advanced Renal Cell Carcinoma Previously Treated With Axitinib: Subgroup Analysis from TIVO-3
Luis Meza, David F McDermott, Bernard Escudier, et al.
Page
of 39
Search research articles
Search
Showing results (181-190 of 388) with videos related to
Sort By:
Page
of 39
Critical Reviews in Oncology/Hematology
|
June 9, 2019
Management of targeted therapies in cancer patients with chronic kidney disease, or on haemodialysis: An Associazione Italiana di Oncologia Medica (AIOM)/Societa' Italiana di Nefrologia (SIN) multidisciplinary consensus position paper
Nicola Silvestris, Antonella Argentiero, Laura Cosmai, et al.
The Oncologist
|
February 6, 2025
Updated overall survival in patients with prior checkpoint inhibitor therapy in the phase III TIVO-3 study
Miguel Zugman, David F McDermott, Bernard J Escudier, et al.
American Journal of Clinical Oncology
|
April 2, 2004
Docetaxel, carboplatin and concomitant radiotherapy for unresectable squamous cell carcinoma of the head and neck: pharmacokinetic and clinical data of a phase I-II study
Mario Airoldi, Luigi Cattel, Giorgio Cortesina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2007
Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma
Andrea Sartore-Bianchi, Fabio Gasparri, Arturo Galvani, et al.
Journal of Cellular Biochemistry
|
February 27, 2016
Endoplasmic Reticulum Ca(2+) Handling and Apoptotic Resistance in Tumor-Derived Endothelial Colony Forming Cells
Valentina Poletto, Silvia Dragoni, Dmitry Lim, et al.
Journal of Nephrology
|
July 24, 2015
Renal cancer in kidney transplanted patients
Giovanni M Frascà, Silvio Sandrini, Laura Cosmai, et al.
International Journal of Molecular Sciences
|
August 6, 2020
Non-Melanoma Skin Cancers: Biological and Clinical Features
Mauro Cives, Francesco Mannavola, Lucia Lospalluti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2007
Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin
Robert G Gish, Camillo Porta, Lucian Lazar, et al.
BMC Nephrology
|
May 12, 2026
Multimodal predictions of end stage chronic kidney disease from asymptomatic individuals for discovery of genomic biomarkers
Simona Rabinovici-Cohen, Daniel E Platt, Toshiya Iwamori, et al.
The Oncologist
|
December 28, 2022
Tivozanib in Patients with Advanced Renal Cell Carcinoma Previously Treated With Axitinib: Subgroup Analysis from TIVO-3
Luis Meza, David F McDermott, Bernard Escudier, et al.
Page
of 39